← FDA Drug Approvals (Drugs@FDA)

ACETYLCYSTEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2021-04-15

Drug application

FDA Application #

ANDA204797

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETYLCYSTEINE

Generic name

Acetylcysteine

Active ingredients

ACETYLCYSTEINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

EXELA PHARMA

First approval

2021-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown